WIN CONSORTIUM IN THE PRESS
Global Leaders in Oncology Voice Support for WIN Consortium's 2013 Symposium in Personalized Cancer Medicine
read more »
NEWSLETTERSubscribe to our newsletter:
- Dr. John Mendelsohn, Director, Khalifa Institute for Personalized Cancer Therapy and Past-President, The University of Texas MD Anderson Cancer Center; Chairman, WIN Consortium
WIN 2013 Symposium
Global oncology leaders Dr. John Mendelsohn (MD Anderson), Dr. Richard Buller (Pfizer), and Richard L. Schilsky (ASCO) discuss the goal of the WIN 2013 Symposium, to be held July 10-12 in Paris, France.